Viewing Study NCT06561334



Ignite Creation Date: 2024-10-26 @ 3:38 PM
Last Modification Date: 2024-10-26 @ 3:38 PM
Study NCT ID: NCT06561334
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-25

Brief Title: Spasmodic Dysphonia Interviews
Sponsor: None
Organization: None

Study Overview

Official Title: The Socioeconomic Impact of Spasmodic Dysphonia Patients and the Role of Botulinum Toxin
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Previous research has shown that patients with voice disorders often have a lower quality of life and struggle with employment Spasmodic Dysphonia SD is a voice disorder that causes abrupt and uncontrollable spasms of the voice box often resulting in the person having lifelong changes in their voice and speech pattern The current mainstay of treatment is injecting botulinum toxin BT injections into the vocal cord to ease the spasms The same research team conducted a pilot study in April 2021 on patients with SD The pilot study used questionnaires and short interviews to understand the livelihood of 10 SD patients It displayed that SD may impact patients quality of life The investigators now aim to run an official research project ethically approved to explore the following questions further

1 Does SD impact the socio-economic lives of its patients If so how
2 What role does BT play in the socio-economic livelihood of SD patients

To answer these questions the investigators aim to interview 20 patients with Spasmodic Dysphonia
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None